PH.HUBBY 1G SUN CREAM INTENSIVE PROTECTION- titanium dioxide, ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triaz United States - English - NLM (National Library of Medicine)

ph.hubby 1g sun cream intensive protection- titanium dioxide, ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triaz

ph hubby co., ltd. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), bemotrizinol (unii: pwz1720cbh) (bemotrizinol - unii:pwz1720cbh) - prevention of hyperpigmentation&aging induced by uva/uvb rays all year-round. apply every morning at the end of the skincare routine of going out.

PH.HUBBY PINK BB TONE UP SUN- titanium dioxide, ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triazine, niacinami United States - English - NLM (National Library of Medicine)

ph.hubby pink bb tone up sun- titanium dioxide, ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triazine, niacinami

ph hubby co., ltd. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), bemotrizinol (unii: pwz1720cbh) (bemotrizinol - unii:pwz1720cbh) - prevention of hyperpigmentation&aging induced by uva/uvb rays all year-round. apply every morning at the end of the skincare routine of going out.

PH.HUBBY BEIGE BB TONE UP SUN- titanium dioxide, ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triazine, niacinam United States - English - NLM (National Library of Medicine)

ph.hubby beige bb tone up sun- titanium dioxide, ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triazine, niacinam

ph hubby co., ltd. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), bemotrizinol (unii: pwz1720cbh) (bemotrizinol - unii:pwz1720cbh) - prevention of hyperpigmentation&aging induced by uva/uvb rays all year-round. apply every morning at the end of the skincare routine of going out.

NIVEA Sun UV Face Sensitive Protect SPF50 Australia - English - Department of Health (Therapeutic Goods Administration)

nivea sun uv face sensitive protect spf50

beiersdorf australia ltd - bemotrizinol,butyl methoxydibenzoylmethane,ethylhexyl triazone,homosalate,methylene bis-benzotriazolyl tetramethylbutylphenol,octocrylene -

SUN PROJECT SKIN-RELIEF SUNCREAM- diethylamino hydroxybenzoyl hexyl benzoate, ethylhexyl triazone, methylene bis-benzotriazolyl United States - English - NLM (National Library of Medicine)

sun project skin-relief suncream- diethylamino hydroxybenzoyl hexyl benzoate, ethylhexyl triazone, methylene bis-benzotriazolyl

thank you farmer co., ltd. - diethylamino hydroxybenzoyl hexyl benzoate (unii: anq870jd20) (diethylamino hydroxybenzoyl hexyl benzoate - unii:anq870jd20), ethylhexyl triazone (unii: xqn8r9sak4) (ethylhexyl triazone - unii:xqn8r9sak4), bisoctrizole (unii: 8nt850t0ys) (bisoctrizole - unii:8nt850t0ys), iscotrizinol (unii: 2utz0qc864) (iscotrizinol - unii:2utz0qc864) - sunscreen helps prevent sunburn

SUN PROJECT SILKY CALMING SUN STICK- diethylamino hydroxybenzoyl hexyl benzoate, ethylhexyl triazone, polysilicone-15, bis-ethyl United States - English - NLM (National Library of Medicine)

sun project silky calming sun stick- diethylamino hydroxybenzoyl hexyl benzoate, ethylhexyl triazone, polysilicone-15, bis-ethyl

thank you farmer co., ltd. - diethylamino hydroxybenzoyl hexyl benzoate (unii: anq870jd20) (diethylamino hydroxybenzoyl hexyl benzoate - unii:anq870jd20), ethylhexyl triazone (unii: xqn8r9sak4) (ethylhexyl triazone - unii:xqn8r9sak4), polysilicone-15 (unii: f8drp5bb29) (polysilicone-15 - unii:f8drp5bb29), bemotrizinol (unii: pwz1720cbh) (bemotrizinol - unii:pwz1720cbh) - sunscreen helps prevent sunburn

BRING GREEN TEA TREE CICA COOLING SUN- diethylamino hydroxybenzoyl hexyl benzoate, ethylhexyl triazone, polysilicone 15, bemotri United States - English - NLM (National Library of Medicine)

bring green tea tree cica cooling sun- diethylamino hydroxybenzoyl hexyl benzoate, ethylhexyl triazone, polysilicone 15, bemotri

cj olive young corporation - diethylamino hydroxybenzoyl hexyl benzoate 3.5% ethylhexyl triazone 3.0% polysilicone-15 2.0% bis-ethylhexyloxyphenol methoxyphenyl triazine 1.5% - sunscreen ■ helps prevent sunburn ■ higher spf gives more sunburn protection ■ proven mild formulation that doesn't cause skin irritation ■ the low-irritant sun cream that soothes the sensitive skin and protects skin from sun exposure with lightweight and fast-absorbing formula ■ this contains tea tree flower/leaf/stem extract and leaf oil and centella asiatica extract

DR.JUCRE REBIRTH WHITE SUN PROTECTION- octinoxate, homosalate, octisalate, avobenzone, ensulizole, octocrylene, bemotrizinol, ni United States - English - NLM (National Library of Medicine)

dr.jucre rebirth white sun protection- octinoxate, homosalate, octisalate, avobenzone, ensulizole, octocrylene, bemotrizinol, ni

naturecell co., ltd. - ethylhexyl methoxycinnamate 7.30% homosalate 6.00% ethylhexyl salicylate 4.50% butyl methoxydibenzoylmethane 4.00% phenylbenzimidazole sulfonic acid 3.50% octocrylene 2.00% bis-ethylhexyloxyphenol methoxyphenyl triazine 1.50% niacinamide 2.0% adenosine 0.04% - sunscreen sunscreen sunscreen sunscreen sunscreen sunscreen sunscreen skin brightening anti wrinkle ■ helps prevent sun burn ■ helps brighten skin tone ■ helps improve wrinkle problem

COMIRNATY ORIGINAL/OMICRON BA.1 (tozinameran/riltozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

comirnaty original/omicron ba.1 (tozinameran/riltozinameran) covid-19 vaccine 15/15 micrograms/0.3 ml suspension for injection vial

pfizer australia pty ltd - riltozinameran, quantity: 50 microgram/ml; tozinameran, quantity: 50 microgram/ml - injection, suspension - excipient ingredients: water for injections; distearoylphosphatidylcholine; trometamol; trometamol hydrochloride; sucrose; 2-((polyethylene glycol)-2000)-n-n-ditetradecylacetamide; ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate); cholesterol - comirnaty original/omicron ba.1 vaccine has provisional approval for the indication below: as a booster dose for active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 18 years of age and older. the use of this vaccine should be in accordance with official recommendations. the decision has been made on the basis of short term immunogenicity and safety data. continued approval depends on the evidence of longer term efficacy and safety from ongoing clinical trials and post-market assessment.

COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

comirnaty original/omicron ba.4-5 (tozinameran/famtozinameran) covid-19 vaccine 15/15 micrograms/0.3 ml suspension for injection vial

pfizer australia pty ltd - tozinameran, quantity: 50 microgram/ml; famtozinameran, quantity: 50 microgram/ml - injection, suspension - excipient ingredients: cholesterol; sucrose; distearoylphosphatidylcholine; ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate); 2-((polyethylene glycol)-2000)-n-n-ditetradecylacetamide; trometamol hydrochloride; water for injections; trometamol - comirnaty original/omicron ba.4-5 vaccine has provisional approval for the indication below:,active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov- 2, in individuals12 years of age and older.,the use of this vaccine should be in accordance with official recommendations.,the decision has been made on the basis of short term immunogenicity and safety data. continued approval depends on the evidence of longer term efficacy and safety from ongoing clinical trials and post-market assessment.